Abstract
White matter hyperintensities (WMHs) are a common manifestation of cerebral small vessel disease, that is increasingly studied with large, pooled multicenter datasets. This data pooling increases statistical power, but poses challenges for automated WMH segmentation. Although there is extensive literature on the evaluation of automated WMH segmentation methods, such evaluations in a multicenter setting are lacking. We performed WMH segmentations in sixty patients scanned on six different magnetic resonance imaging (MRI) scanners (10 patients per scanner) using five freely available and fully-automated WMH segmentation methods (Cascade, kNN-TTP, Lesion-TOADS, LST-LGA and LST-LPA). Different MRI scanner vendors and field strengths were included. We compared these automated WMH segmentations with manual WMH segmentations as a reference. Performance of each method both within and across scanners was assessed using spatial and volumetric correspondence with the reference segmentations by Dice's similarity coefficient (DSC) and intra-class correlation coefficient (ICC) respectively. We found the best performance, both within and across scanners, for kNN-TTP, followed by LST-LPA and LST-LGA, with worse performance for Lesion-TOADS and Cascade. Our findings can serve as a guide for choosing a method and also highlight the importance to further improve and evaluate consistency of methods in a multicenter setting.
Original language | English |
---|---|
Article number | 16742 |
Number of pages | 12 |
Journal | Scientific Reports |
Volume | 9 |
DOIs | |
Publication status | Published - 14 Nov 2019 |
Bibliographical note
AcknowledgementsN.P.A. Zuithoff, assistant professor in Biostatistic Research for his help in the statistical analyses. The TRACE-VCI study is supported by Vidi grant 91711384 and Vici grant 91816616 from ZonMw, The Netherlands, Organisation for Health Research and Development and grant 2010T073 from the Dutch Heart Association to Geert Jan Biessels. Research of the VUMC Alzheimer Center is part of the neurodegeneration research program of the Neuroscience Campus Amsterdam. The VUMC Alzheimer Center is supported by Stichting Alzheimer Nederland and Stichting VUMC fonds. F.B. is supported by the NIHR UCLH biomedical research center.